Companies / CytoDyn Inc.

CytoDyn Inc.

OTC: CYDYCIK 1175680VANCOUVER, WA

Financials · FY2023

Revenue$0
Net income$3.75M
Total debt$40.53M
Cash$15.65M
Diluted EPS$0.00
Shares outstanding1.37B

Ownership

1.37B shares outstanding · as of Mar 31, 2026
0.03%Institutions
Ownership
Institutions0.03%359,979
Public float99.97%1,365,670,021

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Blok TylerChief Legal Officer
——
Brunke Karen JDirector
——
Dunlap RyanDirector
——
Hoffman Robert E.Chief Financial Officer
——
Lalezari Jacob PCEOChief Executive Officer
——
Ndhlovu Lishomwa CDirector
——
Simes Stephen MDirector
——
Urbach Tanya DurkeeDirector
——

Institutional holders 8

View all →
HolderValue% of shares
Nbc Securities, Inc.$44.8K0.01%
Diversified Trust Co$12.8K<0.01%
Williams Jones Wealth Management, LLC.$12.6K<0.01%
Virtue Capital Management, LLC$12.2K<0.01%
Next Capital Management LLC$9.1K<0.01%
Horizon Financial Services, LLC$5.1K<0.01%
Ancora Advisors LLC$2.7K<0.01%
Caz Investments LP$1.1K<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 20, 2026Dunlap Ryan
Director
GrantNon-qualified stock option (right to buy)—+574K
574,385
0.04% of shares
low
Mar 20, 2026Urbach Tanya Durkee
Director
GrantNon-qualified stock option (right to buy)—+574K
574,385
0.04% of shares
low
Mar 20, 2026Simes Stephen M
Director
GrantNon-qualified stock option (right to buy)—+574K
574,385
0.04% of shares
low
Mar 20, 2026Ndhlovu Lishomwa C
Director
GrantNon-qualified stock option (right to buy)—+574K
574,385
0.04% of shares
low
Mar 20, 2026Lalezari Jacob P
CEO
GrantNon-qualified stock option (right to buy)—+4.9M
4,874,691
0.36% of shares
low
Mar 20, 2026Hoffman Robert E.
Executive
GrantNon-qualified stock option (right to buy)—+4.9M
4,874,691
0.36% of shares
low
Mar 20, 2026Brunke Karen J
Director
GrantNon-qualified stock option (right to buy)—+574K
574,385
0.04% of shares
low
Mar 20, 2026Blok Tyler
Executive
GrantNon-qualified stock option (right to buy)—+3.2M
3,249,794
0.24% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CYDYCommon StockEquity23283M101BBG000BYRYW3